Metabolomic identification of diagnostic plasma biomarkers in humans with chronic heart failure.
暂无分享,去创建一个
Bin Li | Wei Wang | Huihui Zhao | Kuo Gao | Junpeng Zhang | Jianxin Chen | Juan Wang | B. Li | Junpeng Zhang | Jianxin Chen | Huihui Zhao | Wei Wang | Juan Wang | Kuo Gao | Zhongfeng Li | Liangtao Luo | Wenting Zhang | Xuegong Xu | Zhongfeng Li | Liangtao Luo | Chan Chen | Xuegong Xu | Wenting Zhang | Bin Li | Chang Chen | Chan Chen
[1] S. Wold,et al. Orthogonal projections to latent structures (O‐PLS) , 2002 .
[2] M. Rantalainen,et al. OPLS discriminant analysis: combining the strengths of PLS‐DA and SIMCA classification , 2006 .
[3] Daniel S Waterman,et al. The influence of EDTA and citrate anticoagulant addition to human plasma on information recovery from NMR-based metabolic profiling studies. , 2010, Molecular bioSystems.
[4] W. Kannel,et al. Changing epidemiological features of cardiac failure. , 1994, British heart journal.
[5] Y Wang,et al. Predictors of readmission among elderly survivors of admission with heart failure. , 2000, American heart journal.
[6] D. Glower,et al. Metabolomic Profiling Reveals Distinct Patterns of Myocardial Substrate Use in Humans With Coronary Artery Disease or Left Ventricular Dysfunction During Surgical Ischemia/Reperfusion , 2009, Circulation.
[7] P. Duez,et al. Metabolic, nutritional, iatrogenic, and artifactual sources of urinary organic acids: a comprehensive table. , 2002, Clinical chemistry.
[8] R. Amathieu,et al. Metabolomic approach by 1H NMR spectroscopy of serum for the assessment of chronic liver failure in patients with cirrhosis. , 2011, Journal of proteome research.
[9] Perry M. Elliott,et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012 , 2010, European journal of heart failure.
[10] H. Nakanishi,et al. Change in the membranous lipid composition accelerates lipid peroxidation in young rat hearts subjected to 2 weeks of hypoxia followed by hyperoxia. , 2008, Circulation journal : official journal of the Japanese Circulation Society.
[11] Peng Xie,et al. Plasma metabonomics as a novel diagnostic approach for major depressive disorder. , 2012, Journal of proteome research.
[12] H. Taegtmeyer,et al. Changes in citric acid cycle flux and anaplerosis antedate the functional decline in isolated rat hearts utilizing acetoacetate. , 1991, The Journal of clinical investigation.
[13] B. McManus,et al. Molecular signatures of end-stage heart failure. , 2011, Journal of cardiac failure.
[14] Juerg Schwitter,et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012 , 2010, European journal of heart failure.
[15] M. Spraul,et al. 750 MHz 1H and 1H-13C NMR spectroscopy of human blood plasma. , 1995, Analytical chemistry.
[16] Jin-Seok Park,et al. A new NMR-based metabolomics approach for the diagnosis of biliary tract cancer. , 2010, Journal of hepatology.
[17] Kyoungmi Kim,et al. Urine Metabolomics Analysis for Kidney Cancer Detection and Biomarker Discovery*S , 2009, Molecular & Cellular Proteomics.
[18] Robert H. G. Schwinger,et al. Epidemiology and economic burden of chronic heart failure , 2004 .
[19] D. Kell,et al. A functional genomics strategy that uses metabolome data to reveal the phenotype of silent mutations , 2001, Nature Biotechnology.
[20] L. A. Bonet,et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012 , 2010, European journal of heart failure.
[21] Stanley Nattel,et al. Proteomic and metabolomic analysis of atrial profibrillatory remodelling in congestive heart failure. , 2010, Journal of molecular and cellular cardiology.
[22] David I. Ellis,et al. Metabolomics: Current analytical platforms and methodologies , 2005 .
[23] S. Silver,et al. Heart Failure , 1937, The New England journal of medicine.
[24] C. Pepine,et al. The role of carnitine in myocardial dysfunction. , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[25] Frederick P Roth,et al. Metabolomic Identification of Novel Biomarkers of Myocardial Ischemia , 2005, Circulation.
[26] J. Nicholson,et al. Rapid and noninvasive diagnosis of the presence and severity of coronary heart disease using 1H-NMR-based metabonomics , 2002, Nature Medicine.
[27] Walter Kolch,et al. Urinary Proteomic Biomarkers in Coronary Artery Disease*S , 2008, Molecular & Cellular Proteomics.
[28] R. Goodacre,et al. The role of metabolites and metabolomics in clinically applicable biomarkers of disease , 2010, Archives of Toxicology.
[29] David I. Ellis,et al. Serum metabolomics reveals many novel metabolic markers of heart failure, including pseudouridine and 2-oxoglutarate , 2007, Metabolomics.
[30] J. Garcia-conde,et al. Serum metabolome analysis by 1H-NMR reveals differences between chronic lymphocytic leukaemia molecular subgroups , 2010, Leukemia.